No Data
No Data
Traws Pharma Announces Results From Study of Tivoxavir Marboxil in Bird Flu
Traws Reports Topline Results From Study Evaluating The Use Of Tivoxavir Marboxil As Treatment For Non-human Primates Challenged With Non-lethal Dose Of H5N1 Bird Flu; Results Build On Earlier Findings Of Mortality Benefit For TXM In Ferrets And Mice
Express News | Traws Pharma Inc - FDA Briefing Documents in Preparation for Discussion of Potential Accelerated Path to Approval
Express News | Traws Pharma Inc - Presents Positive Data for Txm as Bird Flu Treatment at Icar
Express News | Traws Pharma Inc - Enters $50 Million Atm Agreement With Citizens Jmp Securities
Express News | Traws Pharma Shares Are Trading Lower. The Company Announced Topline Results From Ferrets Infected With H5N1 Bird Flu
Yubraj : @Jaguar8 brother how about TNON
Yubraj Yubraj : is it in your radar or not?
Jaguar8 OP Yubraj : Yes it is but it will be on stocks with news which i will post later. Still reviewing others stocks with news. It will be included for sure
Yubraj Jaguar8 OP : thank you
72149607 : what u think about VVPR jag bro pre market today?
View more comments...